Cite
HARVARD Citation
He, Y. et al. (2018). Combined inhibition of PI3Kδ and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia. Cancer letters. pp. 49-59. [Online].